Australia Stock Exchange release from ZELIRA THERAPEUT : Partial Receipt Of Zeliras EDCDM Technology License Fee
09/01/2022 21:49
Australia Stock Exchange release from ZELIRA THERAPEUT ZLD.AX : Partial Receipt Of Zeliras EDCDM Technology License Fee
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility